Eikon Therapeutics, Inc. Common Stock EIKN
$10.83
-1.19%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-08-14 | View → |
| 10-Q | 10-Q | 2026-08-13 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 8-K | 8-K | 2026-08-03 | View → |
| 8-K | 8-K | 2026-06-10 | View → |
| 8-K | 8-K | 2026-06-01 | View → |
| 10-Q | 10-Q | 2026-05-11 | View → |
| 8-K | 8-K | 2026-05-11 | View → |
| 8-K | 8-K | 2026-03-30 | View → |
| 10-K | 10-K | 2026-03-30 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-03-04 | View → |
| 4 | 4 | 2026-02-10 | View → |
| 4 | 4 | 2026-02-09 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 4 | 4 | 2026-02-06 | View → |
| 8-K | 8-K | 2026-02-06 | View → |
| S-1 | S-1 | 2026-01-09 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $10.83
- Market Cap
- $593.65 million
- 52-Week Range
- $7.90 – $17.40
- Average Volume
- 423K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.